Table 2. Platelet, lymphocytes, and PLR values in the study cohort.
No. | Platelet | P-value | Lymphocyte | P-value | PLR | P-value | |
---|---|---|---|---|---|---|---|
Male | 160 | 248.7±98.7 | 0.9 | 2.3±0.9 | 0.8 | 125±73 | 0.4 |
Female | 40 | 278.9±110 | 2.3±0.9 | 137±85 | |||
Obese | 35 | 269.7±110 | 0.3 | 2.4±0.9 | 0.5 | 129±91 | 0.8 |
Non-obese | 165 | 251.5±99.8 | 2.2±0.9 | 127±72 | |||
Smokers | 118 | 252±97 | 0.6 | 2.3±0.9 | 0.4 | 125±75 | 0.6 |
Non-smokers | 82 | 258.6±108.6 | 2.2±0.8 | 131±75 | |||
Hypertensive | 102 | 271.5±111 | 0.01 | 2.2±0.8 | 0.9 | 145±92 | 0.001 |
Non-hypertensive | 98 | 237.2±87.8 | 2.3±0.9 | 109±47 | |||
Diabetic | 88 | 262.9±108 | 0.3 | 2.2±1.0 | 0.9 | 134±86 | 0.3 |
Non-diabetic | 112 | 248.3±96.2 | 2.3±0.8 | 122±65 | |||
Dyslipidemia | 41 | 237.7±78.9 | 0.2 | 2.2±0.8 | 123±58 | 0.6 | |
No dyslipidemia | 159 | 259.1±106 | 2.3±0.9 | 0.4 | 128±79 | ||
Family history | 28 | 244.6±101 | 0.6 | 2.6±0.9 | 0.06 | 104±59 | 0.8 |
No family history | 172 | 256.3±102 | 2.2±0.8 | 131±77 | |||
TIMI 0 | 3 | 373.6±126 | 0.00001 | 1.7±0.5 | 0.00001 | 285±124 | 0.00001 |
TIMI I | 10 | 360.6±115 | 1.6±0.4 | 258±114 | |||
TIMI II | 45 | 302.8±103.5 | 1.8±0.6 | 188±65 | |||
TIMI III | 142 | 228.6±84.6 | 2.2±0.9 | 102±53 | |||
No. of risk factors | 0.5 | ||||||
0 | 12 | 266.42±94.7 | 0.5 | 2.3±0.8 | 0.9 | 122±39 | |
1 | 52 | 233.9±93.9 | 2.3±0.8 | 112±59 | |||
2 | 69 | 265.7±107.1 | 2.3±1.0 | 134±79 | |||
3 | 51 | 256.0±104.2 | 2.2±0.7 | 135±97 | |||
4 | 16 | 261.8±101.3 | 2.4±1.0 | 127±76 | |||
TVR: LAD | 123 | 253.8±103.3 | 0.7 | 2.2±0.8 | 0.07 | 130±73.31 | 0.6 |
LCX | 25 | 270.4±93.7 | 2.5±0.8 | 122±76.4 | |||
RCA | 52 | 249.3±102.7 | 2.4±1.1 | 121±79.8 |
TVR: Target vessel revascularization, LAD: Left anterior descending, LCX: Left circumflex, RCA: Right coronary artery